SLNO实时信号 | 通过Getagraph.com最大化利润

出售 111582 min ago

@ $47.17

发出时间: 15 Feb 2024 @ 02:07

回报率: 0.78%

上一信号: Feb 13 - 02:41

上一信号: 购买

回报率: -2.41 %

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases...

Stats
今日成交量	433 148
平均成交量	378 585
市值	1.59B
EPS	$0 ( 2024-03-19 )
下一个收益日期	( $-0.270 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-20.14
ATR14	$0.151 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Vivo Opportunity, Llc	Sell	750 000	Common Stock
2024-04-30	Vivo Opportunity, Llc	Sell	351 242	Common Stock
2024-04-22	Manning Meredith	Sell	128 000	Employee stock option (right to buy)
2024-04-22	Huang Michael F.	Sell	120 000	Employee stock option (right to buy)
2024-04-01	Yen Kristen	Sell	1 330	Common Stock

INSIDER POWER
-2.77
Last 99 transactions
Buy: 11 116 006 \| Sell: 11 241 097

音量相关性

長: 0.19 (neutral)

短: -0.24 (neutral)

Signal:(38.021) Neutral

Soleno Therapeutics Inc 相关性

10 最正相关
CVV	0.937
MDGL	0.929
EWCZ	0.928
EVCM	0.925
BNFT	0.92
DGHI	0.918
KIN	0.917
RIGL	0.912
EXFO	0.912
GIGM	0.912

10 最负相关
RIVN	-0.913
SOPA	-0.912
LUCD	-0.911
SNPX	-0.906
MTEX	-0.905
PIII	-0.902
OP	-0.899
SMMF	-0.898
ZENV	-0.889
JAN	-0.886

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Soleno Therapeutics Inc 相关性 - 货币/商品

0.82
( strong )

0.85
( strong )

0.68
( moderate )

0.82
( strong )

-0.86
( strong negative )

Soleno Therapeutics Inc 财务报表

Annual	2023
营收:	$0
毛利润:	$-1.96M (0.00 %)
EPS:	$-2.36

FY	2023
营收:	$0
毛利润:	$-1.96M (0.00 %)
EPS:	$-2.36

FY	2022
营收:	$0
毛利润:	$-2.21M (0.00 %)
EPS:	$-2.42

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-7.40

Financial Reports:

No articles found.

Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

实时更新： Soleno Therapeutics Inc [SLNO]

Upcoming Earnings Alert